MD20160079A2 - Sistem de livrare a medicamentului - Google Patents

Sistem de livrare a medicamentului

Info

Publication number
MD20160079A2
MD20160079A2 MDA20160079A MD20160079A MD20160079A2 MD 20160079 A2 MD20160079 A2 MD 20160079A2 MD A20160079 A MDA20160079 A MD A20160079A MD 20160079 A MD20160079 A MD 20160079A MD 20160079 A2 MD20160079 A2 MD 20160079A2
Authority
MD
Moldova
Prior art keywords
thermoplastic polymer
therapeutic agent
delivery system
drug delivery
core
Prior art date
Application number
MDA20160079A
Other languages
English (en)
Russian (ru)
Inventor
Вилли Дж. ВЕРХОВЕН
Граафф Воутер де
Original Assignee
Merck Sharp & Dohme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Corp filed Critical Merck Sharp & Dohme Corp
Publication of MD20160079A2 publication Critical patent/MD20160079A2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

În prezenta invenţie este descris un sistem intravaginal de livrare a medicamentului, care include un nucleu, care conţine un polimer termoplastic şi un agent terapeutic, în care agentul terapeutic este dizolvat în polimerul termoplastic, o membrană, care înconjoară nucleul şi conţine un alt polimer termoplastic, în care agentul terapeutic are o permeabilitate mai redusă în al doilea polimer termoplastic decât în primul polimer termoplastic, şi un alt agent terapeutic în formă solidă inclus într-o porţiune a membranei.
MDA20160079A 2013-12-11 2014-12-08 Sistem de livrare a medicamentului MD20160079A2 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361914500P 2013-12-11 2013-12-11
EP13196737 2013-12-11
PCT/EP2014/076823 WO2015086491A1 (en) 2013-12-11 2014-12-08 Drug delivery system.

Publications (1)

Publication Number Publication Date
MD20160079A2 true MD20160079A2 (ro) 2016-10-31

Family

ID=49759119

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20160079A MD20160079A2 (ro) 2013-12-11 2014-12-08 Sistem de livrare a medicamentului

Country Status (23)

Country Link
US (1) US10413504B2 (ro)
EP (1) EP3079660B1 (ro)
JP (1) JP6251396B2 (ro)
KR (1) KR101808977B1 (ro)
CN (1) CN105979930B (ro)
AP (1) AP2016009223A0 (ro)
AU (1) AU2014363724B2 (ro)
BR (1) BR112016013325B1 (ro)
CA (1) CA2931559C (ro)
CR (1) CR20160261A (ro)
DO (1) DOP2016000132A (ro)
EA (1) EA031802B1 (ro)
HK (1) HK1224208A1 (ro)
IL (1) IL245544A0 (ro)
MA (1) MA39059A1 (ro)
MD (1) MD20160079A2 (ro)
MX (1) MX2016007681A (ro)
PE (1) PE20160680A1 (ro)
PH (1) PH12016501083A1 (ro)
SG (1) SG11201604660VA (ro)
SV (1) SV2016005214A (ro)
TW (1) TW201607563A (ro)
WO (1) WO2015086491A1 (ro)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3079659B1 (en) 2013-12-11 2020-10-28 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
CA2932628A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using a reducing composition and a fixing composition
WO2015095685A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using 2-hydroxypropane-1,2,3-tricarboxylic acid and/or 1,2,3,4-butanetetracarboxylic acid
WO2015095671A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using oxoethanoic acid and/or derivatives thereof
EP3082733A1 (en) 2013-12-19 2016-10-26 The Procter & Gamble Company Shaping keratin fibres using an active agent comprising a functional group selected from the group consisting of: -c(=o)-, -c(=o)-h, and -c(=o)-o-
MX361102B (es) 2013-12-19 2018-11-27 Procter & Gamble Modelado de fibras de queratina con el uso de un agente activo que comprende al menos dos grupos funcionales seleccionados de: -c(oh)- y -c(=o)oh.
CN105828793B (zh) 2013-12-19 2019-06-18 宝洁公司 使用糖使角蛋白纤维成形
WO2015094837A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using carbonate ester
EP3017809A1 (en) * 2014-11-07 2016-05-11 Ferring B.V. Drug-device unit containing quinagolide
EP3297730A1 (en) 2014-12-19 2018-03-28 The Procter and Gamble Company Method of shaping keratin fibres
MX2017008204A (es) 2014-12-19 2017-10-06 Procter & Gamble Conformacion de las fibras de queratina mediante el uso de arabinosa y carbonato de etileno.
EP3310325A1 (en) 2015-06-18 2018-04-25 The Procter and Gamble Company Shaping keratin fibres using dialdehyde compounds
WO2017025104A1 (en) * 2015-08-11 2017-02-16 Ptt Holding Aps A delivery device
EP3395335A1 (en) * 2017-04-24 2018-10-31 Kern Pharma, S.L. Vaginal ring for the simultaneous release of two active ingredients
DE102017113166A1 (de) * 2017-06-14 2018-12-20 Amw Gmbh Depotform zur Abgabe eines Östrogen-Wirkstoffs
CN111971026A (zh) 2018-05-24 2020-11-20 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
EP3801378A4 (en) 2018-05-24 2022-02-23 Celanese EVA Performance Polymers LLC IMPLANTABLE DEVICE FOR THE DELAYED RELEASE OF A MACROMOLECULAR DRUG COMPOUND
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
WO2023141198A1 (en) * 2022-01-21 2023-07-27 The Population Council, Inc. Combination therapy intravaginal rings

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3995634A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3995633A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US4237885A (en) 1978-10-23 1980-12-09 Alza Corporation Delivery system with mated members for storing and releasing a plurality of beneficial agents
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4629449A (en) 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
EP0162492B1 (en) 1984-04-11 1989-08-02 Thiemann Arzneimittel GmbH Dosage units for controlled release of active material
EP0180264A1 (en) 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
US4816258A (en) 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
WO1989009066A1 (en) 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
US5766632A (en) 1993-10-01 1998-06-16 Legere Pharmaceuticals, Ltd. Method of using lectins for contraception
JP3720386B2 (ja) 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
ES2166894T3 (es) 1995-07-04 2002-05-01 Akzo Nobel Nv Dispositivos anulares.
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
DE69817017T2 (de) 1997-12-12 2004-02-26 Akzo Nobel N.V. Verpackung für einen vaginalring
ID25660A (id) 1997-12-18 2000-10-19 Lilly Co Eli Teripatide kristal
US6579533B1 (en) 1999-11-30 2003-06-17 Bioasborbable Concepts, Ltd. Bioabsorbable drug delivery system for local treatment and prevention of infections
IL157771A0 (en) 2001-03-27 2004-03-28 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of an antimicrobial agent
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
US20040247674A1 (en) 2001-08-31 2004-12-09 Timo Haapakumpu Drug delivery system
CN100408029C (zh) 2001-09-28 2008-08-06 麦克内尔-Ppc股份有限公司 有镶嵌部分的组合剂型
CN1242819C (zh) 2002-06-07 2006-02-22 上海市计划生育科学研究所 一种新型***环及制备方法
US6992219B2 (en) 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
WO2005004837A1 (en) 2003-07-10 2005-01-20 Galen (Chemicals) Limited Intravaginal drug delivery devices
DK1670440T3 (da) * 2003-09-29 2014-07-07 Novo Nordisk As HRT formuleringer
ATE434433T1 (de) * 2004-03-24 2009-07-15 Organon Nv Arzneimittelabgabesystem auf basis von polyethylen-vinylacetat-copolymeren
KR20060046263A (ko) * 2004-08-04 2006-05-17 도쿄파츠고교 가부시키가이샤 편평형 진동모터를 내장시킨 전자음향변환기
TW200727920A (en) 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
JP2010509964A (ja) 2006-11-20 2010-04-02 ナームローゼ・フエンノートチヤツプ・オルガノン らせん形薬物送達システム
WO2008100876A1 (en) 2007-02-12 2008-08-21 Particle Sciences, Inc. Delivery devices containing encapsulated and/or particle-bound active pharmaceutical ingredients
PE20081895A1 (es) 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral
MX2010002616A (es) 2007-09-07 2010-08-04 Qlt Plug Delivery Inc Nucleos de farmaco para la liberacion sostenida de agentes terapeuticos.
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2456421B1 (en) * 2009-07-21 2017-04-05 The Population Council, Inc. Multi-layered gradient vaginal ring
EP2468750A1 (en) 2010-12-13 2012-06-27 Chemo Ibérica, S.A. Polymorphic forms of asenapine maleate and processes for their preparation
TW201332585A (zh) 2012-02-14 2013-08-16 Chemo Res S L 核鞘藥物遞送裝置
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system

Also Published As

Publication number Publication date
EA201691193A1 (ru) 2016-09-30
IL245544A0 (en) 2016-06-30
JP6251396B2 (ja) 2017-12-20
EP3079660B1 (en) 2021-03-03
CN105979930A (zh) 2016-09-28
EA031802B1 (ru) 2019-02-28
MA39059A1 (fr) 2018-08-31
HK1224208A1 (zh) 2017-08-18
CA2931559C (en) 2018-03-13
EP3079660A1 (en) 2016-10-19
MX2016007681A (es) 2016-10-14
AU2014363724B2 (en) 2017-02-23
KR20160095110A (ko) 2016-08-10
CR20160261A (es) 2016-08-16
DOP2016000132A (es) 2016-07-31
JP2016539991A (ja) 2016-12-22
CN105979930B (zh) 2019-11-19
PH12016501083A1 (en) 2016-07-25
KR101808977B1 (ko) 2017-12-13
SV2016005214A (es) 2016-11-21
BR112016013325A2 (ro) 2017-08-08
US20150157561A1 (en) 2015-06-11
BR112016013325B1 (pt) 2022-11-29
SG11201604660VA (en) 2016-07-28
US10413504B2 (en) 2019-09-17
AU2014363724A1 (en) 2016-05-26
CA2931559A1 (en) 2015-06-18
AP2016009223A0 (en) 2016-05-31
PE20160680A1 (es) 2016-07-31
TW201607563A (zh) 2016-03-01
WO2015086491A1 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
MD20160079A2 (ro) Sistem de livrare a medicamentului
MX2015012933A (es) Micrordenamiento para suministro de agente terapeutico y metodos de uso.
HK1215666A1 (zh) 藥劑儲存、分配和給藥系統與方法
WO2017091749A8 (en) Shape changing drug delivery devices and methods
MX2016001621A (es) Dispositivos y metodos de unidades multiples para administracion de farmacos.
EP2968770A4 (en) PORTABLE SYSTEM FOR MIXTURE AND DISPOSAL OF MEDICAMENTS AND METHOD
EP3082419A4 (en) Drug mixing and delivery system and method
NZ630213A (en) Methods of treating bladder cancer
EP2983659A4 (en) DRUG DELIVERY POLYMER AND USES THEREOF
SG11201507294WA (en) Drug delivery devices with drug-permeable component and methods
EP3027259A4 (en) Systems and methods for drug delivery, treatment, and monitoring
HK1205908A1 (en) Vascular occlusion and drug delivery devices, systems, and methods
IN2014DN09669A (ro)
TN2016000162A1 (en) Eye device.
MX2016014622A (es) Sistemas de suministro de medicamentos y metodos de uso relacionados.
MX2016011744A (es) Soluciones de buprenorfina de liberacion sostenida.
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
PT3432970T (pt) Dispositivos de administração de fármaco in vivo
AR094289A1 (es) Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
EP2964289A4 (en) DEVICE, SYSTEM AND METHOD OF SUBCUTANEOUS DRUG DELIVERY
MX2017003638A (es) Microparticulas inyectables para liberacion hiper-localizada de agentes terapeuticos.
IN2014DN06817A (ro)
MX2017000141A (es) Nanoparticulas terapeuticas dirigidas y metodos para elaborar y utilizar las mismas.
MX2018005085A (es) Nanoparticulas terapeuticas que comprenden un agente terapeutico y metodos de fabricacion y uso de las mismas.
WO2014203189A9 (en) Nanocarrier system for micrornas and uses thereof

Legal Events

Date Code Title Description
FA9A Abandonment or withdrawal of application (patent for invention)